Does ROSIGLITAZONE Cause Coronary arterial stent insertion? 1,698 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,698 reports of Coronary arterial stent insertion have been filed in association with ROSIGLITAZONE. This represents 3.7% of all adverse event reports for ROSIGLITAZONE.
1,698
Reports of Coronary arterial stent insertion with ROSIGLITAZONE
3.7%
of all ROSIGLITAZONE reports
47
Deaths
994
Hospitalizations
How Dangerous Is Coronary arterial stent insertion From ROSIGLITAZONE?
Of the 1,698 reports, 47 (2.8%) resulted in death, 994 (58.5%) required hospitalization.
Is Coronary arterial stent insertion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 1,698 reports have been filed with the FAERS database.
What Other Side Effects Does ROSIGLITAZONE Cause?
Myocardial infarction (17,018)
Cardiac failure congestive (15,085)
Cerebrovascular accident (7,899)
Coronary artery disease (4,982)
Acute myocardial infarction (2,437)
Cardiac disorder (1,732)
Coronary artery bypass (1,181)
Chest pain (990)
Myocardial ischaemia (970)
Atrial fibrillation (784)
What Other Drugs Cause Coronary arterial stent insertion?
METFORMIN\ROSIGLITAZONE (245)
ADALIMUMAB (175)
EVOLOCUMAB (109)
RANOLAZINE (95)
RISANKIZUMAB-RZAA (94)
AVANDIA (68)
ETANERCEPT (67)
IBRUTINIB (54)
UPADACITINIB (52)
FLUTICASONE\SALMETEROL (45)
Which ROSIGLITAZONE Alternatives Have Lower Coronary arterial stent insertion Risk?
ROSIGLITAZONE vs ROSUVASTATIN
ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN
ROSIGLITAZONE vs ROTIGOTINE
ROSIGLITAZONE vs ROXADUSTAT
ROSIGLITAZONE vs ROXICODONE